CEO Thomas P. Mathers sold $56K of Colucid Pharmaceuticals, Inc.

Sold$55,694

$37.08Price

1,502Shares

−1%Stake

What CLCD did after the filing

Prices for CLCD after this filing aren't in yet.

Traded Wed, Oct 5. Filed Wed, Oct 5, 12:19 PM ET, during the session. Not investment advice.